Congratulations to Florian Kuchenbauer for receiving the Leukemia and Lymphoma Society of Canada (LLSC) Pediatric Blood Cancer Research Innovation Grant for his research entitled, “MiR-193a-based LNP drug treatment for pediatric acute myeloid leukemia.”
The LLSC’s Pediatric Blood Cancer Research Innovation Grant is a two-year grant designed to provide funding to research that will lead to a significant change in the understanding, diagnosis, or treatment of pediatric blood cancers.